Ticker > Company >

Citurgia Biochem share price

Citurgia Biochemicals Ltd.

NSE: CITURGIBIO BSE: 506373 SECTOR: Chemicals  323   0   0

54.86
+2.61 (5.00%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 54.86

Today's Low

₹ 54.86

52 Week High

₹ 52.25

52 Week Low

₹ 47.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

724.67 Cr.

Enterprise Value

731.39 Cr.

No. of Shares

13.21 Cr.

P/E

0

P/B

0

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  -0.73

CASH

0.12 Cr.

DEBT

6.83 Cr.

Promoter Holding

99.36 %

EPS (TTM)

₹  -0.03

Sales Growth

0%

ROE

0 %

ROCE

-1964.73%

Profit Growth

11.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 Year11.04%
3 Year-1.59%
5 Year-1.39%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year-1964.73%
3 Year-725.37%
5 Year-450.92%

Debt/Equity

-0.72

Price to Cash Flow

-6253.72

Interest Cover Ratio

-2681.663

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 99.36 0.00
Sep 2025 99.36 0.00
Jun 2025 99.36 0.00
Mar 2025 99.67 0.00
Dec 2024 99.67 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a high promoter holding of 99.36%.

 Limitations

  • The company has shown a poor profit growth of -1.5875814670298% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of -725.371766666667% over the past 3 years
  • Company has negative cash flow from operations of -0.115879.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 0 0 0 0 0
Total Expenditure 0.08 0.05 0.06 0.03 0.05
Operating Profit -0.08 -0.05 -0.06 -0.03 -0.05
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0.06 0.06 0.06 0.05 0.06
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.14 -0.1 -0.12 -0.08 -0.11
Tax 0 0 0 0 0
Profit After Tax -0.14 -0.1 -0.12 -0.08 -0.11
Adjusted EPS (Rs) -0.01 -0.01 -0.01 -0.01 -0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0 0 0 0 0
Total Expenditure 0.37 0.18 0.21 0.25 0.2
Operating Profit -0.37 -0.18 -0.21 -0.25 -0.2
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0.24 0.23 0.23 0.23 0.23
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.61 -0.4 -0.44 -0.48 -0.42
Tax 0 0 0 0 0
Net Profit -0.61 -0.4 -0.44 -0.48 -0.42
Adjusted EPS (Rs.) -0.23 -0.15 -0.17 -0.18 -0.16

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 26.42 26.42 26.42 26.42 26.42
Total Reserves -31.67 -32.08 -32.51 -32.99 -33.41
Borrowings 6.46 6.46 6.52 6.74 6.8
Other N/C liabilities 1.83 1.83 1.83 1.83 1.83
Current liabilities 8.56 8.8 8.94 9.05 9.13
Total Liabilities 11.6 11.43 11.19 11.04 10.76
Assets
Net Block 1.52 1.3 1.07 0.85 0.62
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 1.81 1.88 1.84 1.89 1.83
Other N/C Assets 0 0 0 0 0
Current Assets 8.27 8.25 8.28 8.3 8.32
Total Assets 11.6 11.43 11.19 11.04 10.76
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.61 -0.4 -0.44 -0.48 -0.42
Adjustment 0.24 0.23 0.23 0.23 0.23
Changes in Assets & Liabilities 0.23 0.15 0.14 0.11 0.08
Tax Paid 0 0 0 0 0
Operating Cash Flow -0.15 -0.03 -0.07 -0.14 -0.12
Investing Cash Flow 0.15 0.01 0.04 -0.05 0.07
Financing Cash Flow 0.01 0 0.06 0.22 0.06
Net Cash Flow 0.01 -0.01 0.02 0.03 0.01

Corporate Actions

Investors Details

PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
promoters 99.67 99.67 99.36 99.36 99.36
dev versha jetro valley p... 27.14 27.14 27.14 27.14 27.14
elite capital & managemen... 0.04 0.04 0.04 0.04 0.04
gandharva holding limited... 5.79 5.79 5.79 5.79 5.79
gem info solutions privat... 5.75 5.75 5.75 5.75 5.75
satya sheel engineers and... 60.64 60.64 60.64 60.64 60.64
jehreen investments limit... 0.05 0.05 - - -
lochness investments limi... 0.05 0.05 - - -
n w exports limited 0.01 0.01 - - -
nessville trading ltd 0.02 0.02 - - -
nowrosjee wadia and sons ... 0.06 0.06 - - -
nusli neville wadia 0.04 0.04 - - -
the bombay burmah trdg co... 0.02 0.02 - - -
the bombay dyeing and man... 0.06 0.06 - - -
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Citurgia Biochem - Quaterly Results 22 Nov, 12:00 AM Citurgia Biochem - Quaterly Results 26 Aug, 4:28 PM Citurgia Biochem - Quaterly Results 26 Aug, 4:28 PM Citurgia Biochem - Quaterly Results 26 Aug, 4:28 PM Citurgia Biochem - Quaterly Results 9 Jun, 4:20 PM Citurgia Biochem - Quaterly Results 9 Jun, 4:20 PM Citurgia Biochem - Quaterly Results 9 Jun, 4:20 PM Citurgia Biochem - Quaterly Results 27 Feb, 5:26 PM Citurgia Biochem - Quaterly Results 27 Feb, 5:26 PM Citurgia Biochem - Quaterly Results 27 Feb, 5:26 PM Citurgia Biochem - Quaterly Results 19 Nov, 6:55 PM Citurgia Biochem - Quaterly Results 19 Nov, 6:55 PM Citurgia Biochem - Quaterly Results 21 Aug, 4:27 PM Citurgia Biochem - Quaterly Results 21 Aug, 4:27 PM Citurgia Biochem - Quaterly Results 21 Aug, 4:27 PM Citurgia Biochem - Quaterly Results 22 May, 6:21 PM Citurgia Biochem - Quaterly Results 22 May, 6:21 PM Citurgia Biochem - Quaterly Results 14 Feb, 5:42 PM Citurgia Biochem - Quaterly Results 14 Feb, 5:42 PM Citurgia Biochem - Quaterly Results 3 Jan, 5:58 PM Citurgia Biochem - Quaterly Results 3 Jan, 5:58 PM Citurgia Biochem - Quaterly Results 3 Jan, 5:58 PM Citurgia Biochemicals submits revised unaudited financial results 29 Dec, 4:40 PM Citurgia Biochemicals informs about closure of trading window 28 Dec, 4:59 PM Citurgia Biochem - Quaterly Results 21 Oct, 2:24 PM Citurgia Biochem - Quaterly Results 21 Oct, 2:24 PM Citurgia Biochem - Quaterly Results 21 Oct, 2:24 PM Citurgia Biochemicals submits revised standalone audited financial results 20 Oct, 5:22 PM Citurgia Biochem - Quaterly Results 27 Jul, 1:49 PM Citurgia Biochem - Quaterly Results 27 Jul, 1:49 PM Citurgia Biochemicals submits board meeting intimation 22 May, 4:24 PM Citurgia Biochemicals submits financial results 15 Feb, 5:26 PM Citurgia Biochem - Quaterly Results 15 Feb, 4:12 PM Citurgia Biochem - Quaterly Results 15 Feb, 4:12 PM Citurgia Biochem - Quaterly Results 23 Jan, 5:41 PM Citurgia Biochem - Quaterly Results 23 Jan, 5:41 PM Citurgia Biochemicals informs about outcome of board meeting 28 Nov, 5:13 PM Citurgia Biochem - Quaterly Results 10 Oct, 3:37 PM Citurgia Biochem - Quaterly Results 10 Oct, 3:37 PM Citurgia Biochem - Quaterly Results 10 Oct, 3:37 PM Citurgia Biochemicals informs about change in directorate 21 Sep, 4:31 PM Citurgia Biochemicals informs about trading window closure 5 Jul, 4:56 PM Citurgia Biochemicals informs about disclosure 6 Dec, 12:46 PM Citurgia Biochemicals submits unaudited financial results 1 Dec, 4:07 PM Citurgia Biochem - Quaterly Results 1 Dec, 2:56 PM Citurgia Biochem - Quaterly Results 1 Dec, 2:56 PM Citurgia Biochem - Quaterly Results 1 Dec, 2:56 PM Citurgia Biochemicals informs about board meeting 11 Nov, 4:42 PM Citurgia Biochemicals submits annual report 8 Oct, 12:02 PM Citurgia Biochemicals informs about compliance certificate 3 Aug, 2:11 PM

Citurgia Biochem Stock Price Analysis and Quick Research Report. Is Citurgia Biochem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Citurgia Biochem. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Citurgia Biochem has a PE ratio of -1648.26498422713 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Citurgia Biochem has ROA of -3.8805% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Citurgia Biochem has a Current ratio of 0.911.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Citurgia Biochem has a ROE of 0%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Citurgia Biochem has a Debt to Equity ratio of -0.72 which means that the company has low proportion of debt in its capital.

  • Sales growth: Citurgia Biochem has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Citurgia Biochem for the current financial year is 0%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Citurgia Biochem is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Citurgia Biochem is Rs -0.0317. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Citurgia Biochem in Ticker for free. Also, one can get the intrinsic value of Citurgia Biochem by using Valuation Calculators, which are available with a Finology ONE subscription. 

Citurgia Biochem FAQs

Q1. What is Citurgia Biochem share price today?
Ans: The current share price of Citurgia Biochem is Rs 52.25.

Q2. What is the market capitalisation of Citurgia Biochem?
Ans: Citurgia Biochem has a market capitalisation of Rs 690.198020875 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Citurgia Biochem?
Ans: The PE ratio of Citurgia Biochem is -1648.26498422713 and the P/B ratio of Citurgia Biochem is -71.2435233160622, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Citurgia Biochem share?
Ans: The 52-week high share price of Citurgia Biochem is Rs 52.25, and the 52-week low share price of Citurgia Biochem is Rs 47.4.

Q5. Does Citurgia Biochem pay dividends?
Ans: Currently, Citurgia Biochem does not pay dividends. Dividend yield of Citurgia Biochem is around 0%.

Q6. What are the face value and book value of Citurgia Biochem shares?
Ans: The face value of Citurgia Biochem shares is Rs 2, while the book value per share of Citurgia Biochem is around Rs -0.7334. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Citurgia Biochem?
Ans: Citurgia Biochem has a total debt of Rs 6.833598 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Citurgia Biochem?
Ans: The ROE of Citurgia Biochem is 0% and ROCE of Citurgia Biochem is -1964.7335%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Citurgia Biochem a good buy for the long term?
Ans: The Citurgia Biochem long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Citurgia Biochem undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Citurgia Biochem appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Citurgia Biochem’s financials?
Ans: You can review Citurgia Biochem’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Citurgia Biochem
X